Skip to main content

Arnau Hervera Abad

Institutions of which they are part

Main researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Arnau Hervera Abad

Institutions of which they are part

Main researcher
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Projects

INHIBICION DE LA HDAC3 COMO TERAPIA PARA LESIONES MEDULARES Y ENFERMEDADES AUTOIMMUNES DEMIELINIZANTES

IP: Arnau Hervera Abad
Collaborators: -
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 66612.39
Reference: PID2020-119769RA-I00
Duration: 01/01/2023 - 31/08/2024

Ministerio de Ciencia

x

IP: Xavier Montalban Gairín
Collaborators: Arnau Hervera Abad, Miriam Izquierdo Sans
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 236350
Reference: RYC2021-033528-I
Duration: 01/01/2023 - 31/12/2027

Ministerio de Ciencia

Related news

In total, different projects of six research groups will be promoted, focusing on precision medicine and advanced therapies.

Dr. Carmen Espejo and Dr. Georgina Arrambide, researchers at Cemcat and Vall d'Hebron Research Institute, are the first authors of the article.

The research findings propose to modify the McDonald 2017 criteria, only in those in whom diagnosis using the current criteria is not possible.

Related professionals

Tomàs Pumarola Suñé

Tomàs Pumarola Suñé

Main researcher
Microbiology
Read more
Raquel Maria Lastra Borras

Raquel Maria Lastra Borras

Research technician
Headache and Neurological Pain
Read more
Laia Blanco Cuso

Laia Blanco Cuso

Hepato-bilio-pancreatic surgery (HBP) and liver transplantation
Read more
Laia Miquel Serra

Laia Miquel Serra

Postdoctoral researcher
Transfusional Medicine
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.